A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

被引：0
|
作者：
Syma Iqbal
Cathryn Rankin
Heinz-Josef Lenz
Philip J. Gold
Syed A. Ahmad
Anthony B. El-Khoueiry
Michael J. Messino
Randall F. Holcombe
Charles D. Blanke
机构：
[1] University of Southern California,Norris Comprehensive Cancer Center
[2] Southwest Oncology Group Statistical Center,Barrett Center, Department of Surgery
[3] Swedish Cancer Institute,undefined
[4] University of Cincinnati,undefined
[5] Southeast Cancer Control Consortium,undefined
[6] Inc. CCOP,undefined
[7] Cancer Care of WNC,undefined
[8] University of California at Irvine,undefined
[9] Chao Family CCC,undefined
[10] University of British Columbia,undefined
[11] and British Columbia Cancer Agency,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Gemcitabine; Capecitabine; Cholangiocarcinoma; Gallbladder; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1595 / 1602
页数：7
相关论文
共 50 条
  • [21] Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer
    Hirooka, Yoshiki
    Ishikawa, Takuya
    Kawashima, Hiroki
    Ohno, Eizaburo
    Nonogaki, Koji
    Kanamori, Akira
    Hirai, Takanori
    Uchida, Hiroki
    Shirai, Osamu
    Ishikawa, Hideki
    Goto, Hidemi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 119 - 125
  • [22] Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer
    Yoshiki Hirooka
    Takuya Ishikawa
    Hiroki Kawashima
    Eizaburo Ohno
    Koji Nonogaki
    Akira Kanamori
    Takanori Hirai
    Hiroki Uchida
    Osamu Shirai
    Hideki Ishikawa
    Hidemi Goto
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 119 - 125
  • [23] PHASE-II TRIAL OF DIMETHYLTRIAZENOIMIDAZOLE CARBOXAMIDE IN PATIENTS WITH METASTATIC CARCINOID - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUKOWSKI, RM
    TANGEN, CM
    PETERSON, RF
    TAYLOR, SA
    RINEHART, JJ
    EYRE, HJ
    RIVKIN, SE
    FLEMING, TR
    MACDONALD, JS
    CANCER, 1994, 73 (05) : 1505 - 1508
  • [24] Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study
    Wolfram E. Samlowski
    Holly Gundacker
    J. Philip Kuebler
    Jeffrey K. Giguere
    Glenn M. Mills
    David E. Schuller
    John F. Ensley
    Investigational New Drugs, 2001, 19 : 311 - 315
  • [25] A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer A Hoosier Oncology Group Study
    Cardenes, Higinia R.
    Moore, Annette M.
    Johnson, Cynthia S.
    Yu, Menggang
    Helft, Paul
    Chiorean, Elena G.
    Vinson, Jacob
    Howard, Thomas J.
    Stephens, Anthony W.
    Tai, D. Fritz
    Loehrer, Patrick J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 460 - 465
  • [26] Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group Phase II study
    Samlowski, WE
    Gundacker, H
    Kuebler, JP
    Giguere, JK
    Mills, GM
    Schuller, DE
    Ensley, JF
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (04) : 311 - 315
  • [27] A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients
    Santini, D.
    Virzi, V.
    Vincenzi, B.
    Rocci, L.
    Leoni, V.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2007, 18 (03) : 576 - 580
  • [28] Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329
    Malhotra, Binu
    Moon, James
    Kucuk, Omar
    Clark, Joseph I.
    Urba, Susan G.
    Wolf, Gregory T.
    Worden, Francis P.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (12): : 1712 - 1717
  • [29] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    Stemmler, H. J.
    diGioia, D.
    Freier, W.
    Tessen, H. W.
    Gitsch, G.
    Jonat, W.
    Brugger, W.
    Kettner, E.
    Abenhardt, W.
    Tesch, H.
    Hurtz, H. J.
    Roesel, S.
    Brudler, O.
    Heinemann, V.
    BRITISH JOURNAL OF CANCER, 2011, 104 (07) : 1071 - 1078
  • [30] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna Ida
    Laera, Letizia
    Marrelli, Daniele
    Roviello, Franco
    Francini, Edoardo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 683 - 690
12345